ClearBridge Investments’s Genomic Health, Inc. GHDX Stock Holding History

ClearBridge Investments’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-416,553	Closed	-$28.3M	–	1171
2019 Q3	$28.3M	Buy	416,553 +75,928	+22%	+$5.21M	0.02%	381
2019 Q2	$19.8M	Sell	340,625 -222	-0.1%	-$13.2K	0.02%	435
2019 Q1	$23.9M	Buy	340,847 +60,432	+22%	+$4.48M	0.02%	402
2018 Q4	$18.1M	Buy	280,415 +96,994	+53%	+$6.8M	0.02%	429
2018 Q3	$12.9M	Buy	+183,421	New	+$10.7M	0.01%	512

ClearBridge Investments's GHDX Position: Q4 2019 in Review

ClearBridge Investments sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 416,553 shares — an estimated $28.3M sold.

ClearBridge Investments first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $28.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

ClearBridge Investments reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
ClearBridge Investments sold 416,553 Genomic Health, Inc. shares in Q4 2019, an estimated $28.3M.
ClearBridge Investments first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
ClearBridge Investments's Genomic Health, Inc. position peaked at $28.3M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on ClearBridge Investments's 13F filing for Q4 2019, filed 14 Feb 2020.